Valion Bio, Inc. (VBIO) Free cash flow 2022–2025
Valion Bio, Inc. (VBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.0MFY2025 · since FY2022: -$8.9M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | -22.9% |
| FY2024 | -$5.7M | +33.7% |
| FY2023 | -$8.6M | +3.4% |
| FY2022 | -$8.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice